| Aug 15, 2014
| 4:34 AM
(Reuters) - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.
The FDA in...
| Aug 14, 2014
| 4:44 PM
The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine.
Word of the investigation came less than a week after Allergan sued...
| Aug 19, 2014
| 11:08 AM
(Reuters) - Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street...
| Aug 19, 2014
| 11:23 AM
With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
| Aug 20, 2014
| 9:43 AM
(Reuters) - A federal judge has issued a temporary restraining order against the U.S. Food and Drug Administration's decision to allow the sale of generic versions of the Hospira Inc sedative Precedex.
Hospira filed a lawsuit in U.S. District Court in...
| Aug 21, 2014
Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth.
The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...
| Aug 14, 2014
| 10:24 AM
NEW YORK (Reuters) - A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the...
| Aug 13, 2014
| 5:00 PM
The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
| Aug 17, 2014
| 2:39 PM
LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.
| Aug 12, 2014
| 2:18 PM
As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted."
In a statement published online late Monday, Mapp...
| Aug 11, 2014
| 9:51 AM
Less than two months after receiving approval for an inhalable form of insulin, MannKind Corp. agreed to license the drug to Paris-based Sanofi in a deal that could provide the Valencia company with $925 million.
Sanofi will initially pay MannKind $150...